Product Information
LIDOCAN IV 5% PATCH is a generic product labeled by PureTek Corporation, priced at $1.9978 per EA under NDC 59088091054. Its NADAC has been published 127 times since May 1, 2024.
FDA first approved this application on Apr 30, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/g
Manufacturer
PureTek CorporationNDC
59088091054
Classification
Generic
Dosage Form
PATCH
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINEApproval Type
Generic (ANDA)
FDA Application
ANDA209190FDA Approved
4/30/2020
TE Code
AB
On Market Since
6/15/2023
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAN IV 5% PATCH has been published 127 times since May 1, 2024, and over the history we have for it it has risen 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9978 per EA |
|---|---|
| All-time high | $2.1435 (Sep 10, 2025) |
| All-time low | $1.7004 (May 1, 2024) |
| 52-week high | $2.1180 |
| 52-week low | $1.9204 |
| Median price | $2.0114 |
| Average price | $1.9899 |
| Largest weekly change | +13.9% (Aug 21, 2024) |
| Weeks tracked | 127 |
| Tracking since | May 1, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PureTek Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine 5% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAN IV 5% PATCH?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAN IV 5% PATCH, manufactured by PureTek Corporation, is $1.9978 per EA (NDC 59088091054), effective Sep 30, 2026.
How has the price of LIDOCAN IV 5% PATCH changed over time?
Over the history we have for it, the NADAC for LIDOCAN IV 5% PATCH has risen 17.5%. It has been tracked across 127 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for LIDOCAN IV 5% PATCH?
Since May 1, 2024, the NADAC for LIDOCAN IV 5% PATCH has ranged from a low of $1.7004 (May 1, 2024) to a high of $2.1435 (Sep 10, 2025), with a median of $2.0114 per EA.
Are there cheaper alternatives to LIDOCAN IV 5% PATCH?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE 5% PATCH, is $1.9418 per EA — about 3% below LIDOCAN IV 5% PATCH.
Who manufactures LIDOCAN IV 5% PATCH?
LIDOCAN IV 5% PATCH (NDC 59088091054) is labeled by PureTek Corporation, and CMS classifies it as a generic product.